Literature DB >> 34374444

Is His-optimized superior to conventional cardiac resynchronization therapy in improving heart failure? Results from a propensity-matched study.

Jacopo Senes1, Giuseppe Mascia2, Nicola Bottoni3, Daniele Oddone1, Paolo Donateo1, Teresa Grimaldi3, Calogero Minneci4, Iacopo Bertolozzi4, Michele Brignole1, Enrico Puggioni1, Giovanni Coluccia1.   

Abstract

BACKGROUND: His bundle pacing (HBP), alone or optimized in association with coronary sinus pacing (HBP+LV) has recently been proposed as an alternative to conventional cardiac resynchronization therapy (CRT). However, there is lack of controlled studies that assessed clinical outcome.
METHODS: We did a single-center, propensity-score matched, case-control study of comparison of HBP and HBP+LV versus conventional CRT in patients with heart failure (HF) and standard indications for CRT. The study group patients were consecutively enrolled in the year 2019. The control group patients were selected, by propensity score matching, among those CRT implantations performed in the years 2015-2018.
RESULTS: There were 27 patients in each group. In the active group, 12 (44%) patients received HBP alone and 12 (44%) patients HBP+LV pacing. HBP failed in three (11%) patients. In the control group, conventional CRT was achieved in 26 (96%) patients and failed in one. Paced QRS width was shorter in the active than in the control group (128 ± 18 vs. 148 ± 27 ms, p = .004). During a mean of 9.6 months of follow-up, a composite clinical outcome of death, hospitalization for HF or worsening HF occurred in three (11%) in the active group and in four (15%) in the control group, p = .58. No difference was also observed with softer endpoints: NYHA class (1.9 ± 0.7 vs. 2.1 ± 0.7), subjective improvement (74% vs. 74%) and LV ejection fraction (40.7% vs. 40.7%).
CONCLUSION: Compared with conventional CRT, a shorter QRS width can be obtained with HBP alone or in association with coronary sinus pacing but we were unable to show a better clinical outcome. There is urgent need for large, randomized trials.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  ablate and pace; biventricular pacing; cardiac resynchronization therapy; heart failure; his bundle pacing

Mesh:

Year:  2021        PMID: 34374444     DOI: 10.1111/pace.14336

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Acute Hemodynamic Effects of Simultaneous and Sequential Multi-Point Pacing in Heart Failure Patients With an Expected Higher Rate of Sub-response to Cardiac Resynchronization Therapy: Results of Multicenter SYNSEQ Study.

Authors:  Maciej Sterliński; Joanna Zakrzewska-Koperska; Aleksander Maciąg; Adam Sokal; Joaquin Osca-Asensi; Lingwei Wang; Vasiliki Spyropoulou; Baerbel Maus; Francesca Lemme; Osita Okafor; Berthold Stegemann; Richard Cornelussen; Francisco Leyva
Journal:  Front Cardiovasc Med       Date:  2022-05-12

Review 2.  Alternative pacing strategies for optimal cardiac resynchronization therapy.

Authors:  Juan Hua; Qiling Kong; Qi Chen
Journal:  Front Cardiovasc Med       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.